26 May 2013
Keywords: r-pr, reports, new, data, anticancer, agents, rhone-poulenc
Article | 11 November 1996
Rhone-Poulenc Rorer released results of further clinical trials with its anticancer agents Taxotere (docetaxel) for the treatment of lung, head, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.